Idarucizumab brand name

Idarucizumab, sold under the brand name Praxbind, is a medication used to reverse the effects of dabigatran. Specifically it is used if

Idarucizumab, sold under the brand name Praxbind, is a monoclonal antibody used as a reversal agent for dabigatran. Idarucizumab

Boehringer Ingelheim has developed idarucizumab, Brand Names Related Safety Reports Scientific Summary Pharmacokinetics Adverse events Pharmacodynamics

Idarucizumab. Talimogene Laherparepvec. These aren't made-up In most cases, manufacturers pick the brand name after defining the

Name of medicine (generic brand name): Idarucizumab (Praxbind). Strength(s) and form(s): 2.5 g/50 mL solution for injection/infusion. Dose and

Pradaxa. The approval of the antidote, known by the brand name Praxbind and the generic name idarucizumab, makes Pradaxa the first in its

Idarucizumab. Generic name: idarucizumab [ EYE-da-roo-KIZ-ue-mab ] Brand name: Praxbind Dosage form: intravenous solution (2.5 g/50 mL) Drug class: Anticoagulant reversal agents. Medically reviewed by Drugs.com on . Written by Cerner Multum. Uses; Side effects; Warnings; Before taking; Dosage; Interactions

Lists the various brand names available for medicines containing idarucizumab. Find information on idarucizumab use, treatment, drug class and molecular formula.

by S Heuts 2024 Cited by 1Pharmacological properties of idarucizumab and andexanet alfa . Idarucizumab . Andexanet alfa . Brand name, Praxbind. Ondexxya. Andexxa. Target, Dabigatran.